SARS-CoV-2 infection activating a novel variant of the NOTCH3 gene and subsequently causing development of CADASIL

INTRODUCTION: In the following study we describe the diagnostic process and further case analysis of a 30-year-old woman admitted with typical COVID-19 symptoms, who subsequently developed additional symptoms suggesting cerebral autosomal dominant arteriopathy with sub-cortical infarcts and leukoencephalopathy (CADASIL). MATERIAL AND METHODS: Other than the standard diagnostic procedures, whole genome sequencing (WGS) was used, which led to following findings. A new variant of the NOTCH3 gene, which led to CADASIL-like symptoms, was found, and it had been most likely activated by the SARS-CoV-2 infection. This novel variant in NOTCH3 has not been found in existing databases and has never been mentioned in research concerning CADASIL before. RESULTS: Furthermore, after subjecting the patient’s close relatives to WGS it was found that no other examined person demonstrated the same genetic mutation. CONCLUSIONS: It seems therefore that the new variant of NOTCH3 is of de novo origin in the patient’s genome. Additionally, the relatively early onset of CADASIL and the unexpectedly severe COVID-19 infection suggest that the two occurred simultaneously: the infection with SARS-CoV-2 accelerated development of CADASIL symptoms and the unusual variant of the NOTCH3 gene contributed to the more severe course of COVID-19.